Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Morhulin is an over-the-counter topical ointment used for the treatment of minor skin conditions such as nappy rash, eczema, minor wounds, grazes, pressure sores, and varicose ulcers. The formulation contains two primary active ingredients: zinc oxide (38% w/w) and cod liver oil (11.4% w/w). Zinc oxide functions as a protective barrier and assists in the debridement of dead tissue from wounds, while cod liver oil, containing vitamin A, promotes the healing process and skin regeneration. Originally developed by Thornton & Ross, the product is currently owned by Actavis Group PTC ehf and is supplied as a smooth, white ointment for topical application.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Morhulin.